| Literature DB >> 25987283 |
Stéphanie Debette1, Annette Compter2, Marc-Antoine Labeyrie3, Maarten Uyttenboogaart4, Tina M Metso5, Jennifer J Majersik6, Barbara Goeggel-Simonetti7, Stefan T Engelter8, Alessandro Pezzini9, Philippe Bijlenga10, Andrew M Southerland11, Olivier Naggara12, Yannick Béjot13, John W Cole14, Anne Ducros15, Giacomo Giacalone16, Sabrina Schilling17, Peggy Reiner18, Hakan Sarikaya19, Janna C Welleweerd20, L Jaap Kappelle2, Gert Jan de Borst20, Leo H Bonati21, Simon Jung7, Vincent Thijs22, Juan J Martin23, Tobias Brandt24, Caspar Grond-Ginsbach25, Manja Kloss25, Tohru Mizutani26, Kazuo Minematsu27, James F Meschia28, Vitor M Pereira29, Anna Bersano30, Emmanuel Touzé31, Philippe A Lyrer21, Didier Leys32, Hugues Chabriat18, Hugh S Markus33, Bradford B Worrall11, Stéphane Chabrier34, Ralph Baumgartner35, Christian Stapf18, Turgut Tatlisumak5, Marcel Arnold7, Marie-Germaine Bousser18.
Abstract
Spontaneous intracranial artery dissection is an uncommon and probably underdiagnosed cause of stroke that is defined by the occurrence of a haematoma in the wall of an intracranial artery. Patients can present with headache, ischaemic stroke, subarachnoid haemorrhage, or symptoms associated with mass effect, mostly on the brainstem. Although intracranial artery dissection is less common than cervical artery dissection in adults of European ethnic origin, intracranial artery dissection is reportedly more common in children and in Asian populations. Risk factors and mechanisms are poorly understood, and diagnosis is challenging because characteristic imaging features can be difficult to detect in view of the small size of intracranial arteries. Therefore, multimodal follow-up imaging is often needed to confirm the diagnosis. Treatment of intracranial artery dissections is empirical in the absence of data from randomised controlled trials. Most patients with subarachnoid haemorrhage undergo surgical or endovascular treatment to prevent rebleeding, whereas patients with intracranial artery dissection and cerebral ischaemia are treated with antithrombotics. Prognosis seems worse in patients with subarachnoid haemorrhage than in those without.Entities:
Mesh:
Year: 2015 PMID: 25987283 DOI: 10.1016/S1474-4422(15)00009-5
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182